Who can independently scrutinise my decision?
UHNW Aesthetics is an internationally active specialist review institution for decisions of exceptional consequence in aesthetic medicine.
The focus is your specific proposed treatment: its medical indication, the practitioner already selected, the team, the infrastructure, identifiable risks and the long-term strategy. Professor-led specialist expertise turns reputation, personal recommendations and publicly available information into a robust basis for decision-making.
Within this engagement, the institution undertakes independent review only. The decisive question is whether the clinical, staffing and organisational conditions surrounding the proposed procedure genuinely meet your safety requirements.
You decide on the basis of examined substance—not public perception.What role does UHNW Aesthetics have in our mandate?
UHNW Aesthetics provides the specialist medical review within your existing mandate.
The family office retains responsibility for the relationship and overall coordination. The institution undertakes the specialist review that cannot be derived from general advice or public reputation: the indication, the practitioner's case-specific competence, team, clinical infrastructure, risk control, aftercare and long-term strategy.
Medical statements, unresolved questions and identifiable weaknesses are organised within a traceable decision framework. Your office gains specialist rigour without having to act as a medical expert.
The family office leads. UHNW Aesthetics is responsible for the specialist rigour of the review.What specialist capability does UHNW Aesthetics add?
Your agency knows the client and the client's international circumstances; UHNW Aesthetics examines the clinical basis of the decision.
The selected or specifically contemplated proposal is examined for documented specialist expertise, the capability of the team and facility, emergency arrangements, complication management, aftercare and future revision capability. Public visibility is kept rigorously separate from specialist evidence.
The relationship, communication and organisational leadership remain with your agency. UHNW Aesthetics adds the professor-led depth of review required to support a demanding client beyond access and coordination alone.
Your agency retains the relationship. We examine the system behind the selection.What will I learn beyond reputation and recommendations?
You gain the specialist perspective behind ratings, recommendations, television appearances and social-media visibility.
These signals describe recognition and public perception. They show only to a limited extent whether a treatment is appropriate in your particular case and whether the practitioner, team and facility possess the necessary specialist and organisational depth.
UHNW Aesthetics examines specialisation, outcome evidence, team stability, risk management, emergency capability, revision expertise and long-term responsibility. You gain the specialist perspective required to ask informed questions on equal professional footing anywhere in the world and to reach your own reasoned decision.
You do not delegate your decision to reputation—you have its substance examined.What value does this add to our decision process?
A reputation-led selection becomes a traceable decision framework in aesthetic medicine.
The review separates documented competence from public perception, identifies information gaps and shows what must be resolved before approval is given: the medical rationale, the practitioner's personal responsibility, the team, the facility, aftercare and revision planning.
This structure supports internal assessment and communication with the principal. Risks become visible at an early stage, escalation points are placed in a clear order and opinions from outside the relevant discipline are supplemented by professor-led review.
The office receives an auditable decision process rather than another recommendation.How does the review strengthen our client service?
Your knowledge of the market and the client is extended by an independent medical review layer.
UHNW Aesthetics examines whether your selection is sound not only organisationally and reputationally, but also medically: the suitability of the proposed treatment, the practitioner's specialisation, team quality, the resilience of the facility and the management of complications and long-term consequences.
You can therefore offer the client more than access and coordination. You bring specialist guidance to the process—guidance that recognises marketing as marketing and asks the questions that routinely remain unanswered outside the relevant medical discipline.
International client service gains substance through specialist review within the relevant discipline.Which elements of my proposed treatment are examined?
The review begins with the indication and extends to the long-term revision capability of the entire care system.
It examines your starting position, the plausibility of the proposed procedure, alternatives and limits, together with the selected practitioner's specific specialisation, aesthetic judgement and case-specific competence.
The team, operating and emergency environment, documentation, aftercare, complication management and future revisions are equally important. Procedure numbers are only one data point; the decision becomes robust only when all levels are considered together.
The decision is examined as a system—not as an isolated procedure.Which risks across the care pathway are examined?
We examine the entire chain of responsibility, from the indication through to long-term aftercare.
This includes the medical rationale, the practitioner's specific competence for the case, team stability and the technical and organisational capability of the facility. Particular attention is paid to the points of handover between those involved.
Who is available outside the operating theatre? How are complications recognised and escalated? Who is responsible for aftercare, emergency care and revision—particularly when treatment takes place abroad? The result is a systemic risk review for the engagement.
A robust engagement requires a robust chain of responsibility.How deeply is an existing proposal examined?
An existing proposal is examined for indication, specialist evidence and operational resilience.
The review establishes whether the proposed treatment fits the specific concern, what specialisation and comparable experience the practitioner can evidence, and how meaningful the qualifications presented actually are.
It then considers the team, facility, operating conditions, emergency arrangements, documentation, aftercare, complication management and revision capability. Rather than a new provider list, you receive a precise assessment of your selection: its robust elements, unresolved questions and the evidence that should be requested.
We do not replace your selection—we make its resilience visible.What can I access before an individual review?
Once access is approved, you can enter the knowledge area relevant to your specific concern.
There you learn which medical and organisational factors matter for the particular aesthetic procedure. The material identifies typical areas of risk, relevant indicators of qualification, frequently overlooked dependencies and the questions that should be answered before a decision is made.
You can assess a practitioner's statements more precisely and consider the quality of a proposal beyond its public presentation. If the need for an individual review becomes apparent, the next pathway is clearly defined.
Protected knowledge turns uncertainty into a precise question.How can our team use the protected knowledge?
Your staff receive indication-specific review criteria for preparation, documentation and decision-making.
The protected knowledge sets out typical risk scenarios, specific questions and the evidence that carries genuine weight when assessing the practitioner, team and facility. Public statements can therefore be distinguished from professionally reliable information.
A structured decision framework is available even before an individual case review. The office can identify what the knowledge base can resolve and when a confidential professor-led case review should be initiated.
For the family office, knowledge becomes an operational review tool.How does general knowledge become case-specific guidance?
You receive not a general library, but a defined knowledge area for the specific field of treatment.
The material can be integrated directly into your preparation: required records, relevant qualifications, questions concerning the team and facility, emergency provision, aftercare and long-term strategy.
If the case goes beyond the guidance, a case-specific review framework is initiated. A strategy and process plan defines the information required, the relevant disciplines, confidentiality and the subsequent decision stages before sensitive case data are introduced.
Specialist knowledge becomes specific preparation for your client.Could the review lead to a treatment offer?
The professor-led expertise within UHNW Aesthetics is devoted exclusively to examining your decision.
The institution neither develops a treatment offer from its findings nor refers you to a particular doctor or clinic. It receives no referral commission and holds no financial interest in a reviewed doctor or clinic. This structural boundary remains in place even if you expressly request clinical treatment.
Professors and specialists make requirements, competence, risks and long-term consequences visible. Clinical delivery remains institutionally separate, allowing the assessment to focus solely on the resilience of your decision.
Professor-led authority examines the decision—it does not recruit patients or generate treatment business.How do we verify independence from provider interests?
Independence is embedded in the review engagement and is traceable for every specialist involved.
Each expert receives a defined question, a limited information scope and an exclusively reviewing role. Function, specialist suitability and any potential connection with the practitioner or facility are examined before the expert becomes involved.
The family office can therefore see who is involved, why that person is involved and the precise opinion they have been asked to provide. Professor-led expertise is used solely for review and strategy; clinical delivery, referrals, referral commissions and provider interests remain outside this structure.
The role of every expert is defined before that expert becomes involved.Does our client relationship remain protected?
Your agency continues to lead the client relationship, communication and organisational support.
UHNW Aesthetics enters the process as a distinct specialist review institution. It examines the existing selection against the indication, competence, team, infrastructure, risk and long-term resilience.
No parallel referral channel is created, no referral commission is received and no financial interest is held in the reviewed provider. Your agency remains the client's trusted point of contact and coordination; UHNW Aesthetics undertakes only the specialist review in aesthetic medicine.
Your agency retains the client relationship. UHNW Aesthetics retains responsibility for specialist review.What if my concern exceeds the published guidance?
A complex concern begins with a defined strategic process—not an impromptu remote opinion.
Before any expert becomes involved, the subject of review, the information required, the relevant disciplines and the sequence of the next stages are defined. Your identity is kept separate from the medical question.
Selected professors and internationally recognised specialists receive only the de-identified information required for their stated task. The participants, their functions and the scope of information are disclosed to you in advance; only then does the case-specific review begin.
Complexity produces more structure—not more participants without a defined task.How do we initiate a professor-led case review?
The individual case review begins with a confidential review plan that your family office can control.
It defines the medical question, the records required, the relevant disciplines and the sequence of review stages. Access-review data and case data remain organisationally separate.
On the basis of this plan, the office decides which de-identified information is released. Experts, tasks, information scope and confidentiality arrangements are identified before a professor-led specialist review begins.
The family office retains control of both information and process.When are additional specialists involved?
Additional specialists are involved only for a specifically defined, unresolved specialist question.
Your agency first receives an escalation plan setting out the unresolved question, the expertise required, the records to be prepared in de-identified form and the communication route to the client.
For particularly demanding cases, internationally recognised specialists in the relevant field are involved for that purpose alone. Their access remains limited to the specific point under review; the reason, participants and process are disclosed to your agency in advance.
Every additional specialist authority has a defined remit and a defined information boundary.Why is exceptional private access personally assessed?
Direct private access is reserved for exceptional cases within a restricted cohort of UHNW principals.
The preliminary access review establishes whether your profile, concern and eligibility meet the requirements of this model and the defined client circle. Personal information and any necessary supporting evidence are assessed through a separate protected process; the open first-contact channel is used solely for the access review.
This selection preserves the institution's focus on a clearly defined constituency. Protected knowledge, personal communication and any subsequent individual case review become available only after a positive access decision.
Direct private access is an exceptional decision made individually.Must we disclose our principal's identity?
For the preliminary professional access review, the focus is your family office—not the identity of the principal.
The review concerns the organisation, the applicant's role and the authority to represent the defined UHNW constituency. Client names, financial information and medical details do not form part of this stage.
Your office establishes access through its own institutional standing. Only when a specific case review begins does a defined plan determine which de-identified medical information is required.
Institutional credentials open the route without disclosing the principal.What is required for our initial credentials review?
Your agency establishes eligibility through its own institutional standing and professional activity.
The required information is the verifiable identity of the organisation, the applicant's role, authority to act and the nature of the agency's work within the relevant international client segment.
The names of represented clients and personal case data are not required at this stage. Following a positive preliminary review, personal contact is established and the appropriate protected route is agreed.
The agency is reviewed. Its clients remain outside the preliminary access review.Who learns my identity during specialist review?
Your access review and the specialist case review are maintained as separate information domains.
Professors and specialists are not given your full identity, only the de-identified medical and organisational information required for their specific task.
Before any case material is presented, the participants, their function and the scope of information are identified. Non-disclosure agreements and defined access boundaries ensure that you know in advance who will assess which part of your case.
Your identity remains separate from the specialist question submitted for professor-led review.How is our principal protected across disciplines?
Access-review data, identifying data and specialist case data remain organisationally separate.
For each discipline, the information required is defined separately. The reviewer receives only the de-identified extract relevant to the stated question.
Participants, access rights and confidentiality rules are disclosed in advance. Your family office therefore controls each layer of information, including in an international or multidisciplinary review.
Control of information remains with the family office.How do we control the flow of client information?
Before any expert becomes involved, your agency receives a complete overview of the participants and the proposed information scope.
The specialist function, specific question, required records and intended level of access are identified. Case records are de-identified and limited to the relevant review purpose.
Communication follows the agreed point of contact. This avoids uncoordinated multiple approaches and enables your agency to maintain a consistent, controlled line with the client.
No specialist receives more information than the defined review task requires.Who is accountable for the review?
UHNW Aesthetics is an internationally active specialist review institution with a non-profit structure, under the medical leadership of Prof. Dr. med. A. Altintas, M.Sc.
The institution's medical leadership is held by a specialist in plastic and aesthetic surgery and is dedicated to review, interpretation and strategic support. No clinical service is offered through that function.
Case-specific work is professor-led and assigned within the relevant discipline. For complex questions, selected professors and internationally recognised specialists are involved, always on the basis of documented suitability for the specific review task.
Responsibility is personally identified and professionally verifiable.What must be verifiable before engagement?
Your office is presented with a clearly identified institution, personally accountable medical leadership and defined limits of service.
Before an engagement, the organisational form, titles, professional qualifications and responsibilities must be traceable. It must also be clear who leads the review, which specialist is responsible for each part and where the boundary with clinical treatment lies.
The non-profit structure, international scope and professor-led specialist framework form the institutional basis. Suitability for engagement rests on specific accountability and documented specialist competence.
The family office can attribute responsibility, role and specialist standard unambiguously.Which medical authority can we identify?
You can identify personally accountable medical leadership and a professor-led specialist structure.
Prof. Dr. med. A. Altintas, M.Sc., a specialist in plastic and aesthetic surgery, is responsible for the institution's review and strategic direction. University professors and selected international specialists are involved according to the question under review.
Your client can therefore see who carries institutional responsibility, the standard by which experts are selected and why specialist review remains separate from subsequent treatment.
Your agency can identify a specific professional authority—not an anonymous advisory structure.Can the review support planned treatment abroad?
UHNW Aesthetics is accessible internationally and can assess a proposed treatment across borders.
The review considers not only the doctor and clinic, but also records, international availability, aftercare, emergency access, revision capability and the transfer of responsibility between the parties involved.
Before treatment, these elements are brought together in a coordinated decision and safety framework. Local clinical care remains with the treating system; its resilience forms part of the review.
The place of treatment may change—the review methodology remains consistent.How is a cross-border engagement kept manageable?
An international engagement begins with a clear map of responsibility.
It identifies who makes medical decisions, which records must remain available across borders and who is responsible for complications, aftercare or revision.
UHNW Aesthetics brings specialist questions, regional responsibilities, documentation requirements and escalation routes together in a structured review plan. Your office therefore retains oversight even where several jurisdictions and participants are involved.
Cross-border support requires defined handovers rather than geographical promises.What does international availability mean in practice?
International availability means a consistent professor-led review method combined with clearly defined local responsibility.
Your agency receives a central point of contact. Records, local care, aftercare and escalation routes are assessed for the relevant treatment jurisdiction; additional disciplines are involved within the agreed confidentiality framework.
This enables you to support the client consistently across borders without overlooking local circumstances, legal limits or the actual availability of care providers.
International engagements follow one review methodology with clear local responsibility.What supports exceptional direct private access?
Exceptional direct private access is preferably introduced through a family office, appointed agency or authorised representative. Only where that route is unavailable does the protected review of identity, access eligibility and fit begin.
Where no professional introduction is available, substantive and verifiable evidence must make eligibility for the defined UHNW constituency plausible. It is requested only through the protected process after a positive initial review. Verifiable membership of established private networks may also be considered—for example R360 Global, Augusta National, Yellowstone Club or Yacht Club de Monaco. These examples are potential eligibility signals and imply no institutional affiliation with UHNW Aesthetics.
Payment-card and credit-card programmes carry no evidential weight in the access review. Following a positive initial review, the supporting evidence required through the protected route is agreed with you directly.
Exceptional direct private access depends on verifiable eligibility and an individual access decision.How do we establish eligibility without naming the principal?
Your family office establishes eligibility through its organisation, role and professional authority to act.
The review concerns your institutional standing and authority to represent the relevant UHNW client segment. The principal's name, financial circumstances and medical records are not requested at first contact.
Digital submission of credentials is followed by personal assessment by the responsible access team. If access is approved, the professional route is opened and a named contact is assigned for the next stage.
The standing of the family office is sufficient for preliminary review—the principal remains protected.What must a first-time agency establish?
New agencies are assessed on the basis of their own professional standing.
The relevant criteria are verifiable organisational identity, activity within the relevant international client segment, the applicant's role and authority to act. Names or personal records of represented clients are not required for this stage.
Established partners use the existing protected route. New agencies submit their credentials through the preliminary access review and are then assessed personally by the responsible access team.
Professional credentials open the agency route—not disclosure of a client.What happens once my access is approved?
Once access is approved, you can enter the protected knowledge area relevant to your specific concern.
By appointment, a personal contact guides you through the relevant material online or in person, explains the next stage and identifies which questions can already be answered from the available knowledge.
If your concern requires an individual review, a separate strategy and process plan is then prepared. Only on that basis does de-identified, case-specific work with selected specialists begin.
Access approval connects protected knowledge with a personally guided next step.How does our work begin once access is approved?
Following approval, your family office receives the relevant protected knowledge and a structured personal introduction.
Your staff learn how to use the material, which records should be prepared for a particular concern and when an individual review is indicated. The principal's identity is not disclosed through general access.
An individual case begins with a confidential review plan. It defines the question, data scope, disciplines, de-identification and the subsequent decision stages.
Your office receives immediately usable knowledge and a defined route into individual case review.What do we receive after our credentials are approved?
Approval opens a protected working environment for your agency, supported by a named contact.
A named contact explains how the material can be used for different questions in aesthetic medicine and how specific client cases should be prepared. This provides specialist guidance before personal or medical details enter the process.
For a complex concern, a separate review engagement is then defined. Strategy, confidentiality, information scope and the specialists required are established before case-specific work begins.
Your agency gains access to specialist knowledge without disclosing its client relationship.
